Chemed Corporation (NYSE:CHE) Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas decreased its position in shares of Chemed Corporation (NYSE:CHE - Free Report) by 26.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,793 shares of the company's stock after selling 4,985 shares during the period. Teacher Retirement System of Texas owned about 0.09% of Chemed worth $8,487,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of CHE. Whipplewood Advisors LLC raised its holdings in Chemed by 54.5% in the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after acquiring an additional 18 shares in the last quarter. Impact Capital Partners LLC raised its holdings in Chemed by 2.7% in the first quarter. Impact Capital Partners LLC now owns 763 shares of the company's stock valued at $469,000 after acquiring an additional 20 shares in the last quarter. CBIZ Investment Advisory Services LLC raised its holdings in Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after acquiring an additional 22 shares in the last quarter. CIBC Private Wealth Group LLC increased its stake in Chemed by 13.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock valued at $98,000 after purchasing an additional 22 shares during the last quarter. Finally, KFG Wealth Management LLC increased its stake in Chemed by 4.6% during the first quarter. KFG Wealth Management LLC now owns 525 shares of the company's stock valued at $323,000 after purchasing an additional 23 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Analysts Set New Price Targets

CHE has been the subject of several research analyst reports. Wall Street Zen downgraded shares of Chemed from a "buy" rating to a "hold" rating in a report on Saturday. Royal Bank Of Canada restated an "outperform" rating and issued a $640.00 price objective (down previously from $674.00) on shares of Chemed in a report on Monday, June 30th. Finally, Bank of America lowered their price target on Chemed from $708.00 to $650.00 and set a "buy" rating on the stock in a report on Monday, June 30th.

Insider Transactions at Chemed

In other Chemed news, EVP Spencer S. Lee sold 1,500 shares of Chemed stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the transaction, the executive vice president directly owned 14,627 shares of the company's stock, valued at $8,454,259.73. The trade was a 9.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 1,500 shares of Chemed stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $576.45, for a total value of $864,675.00. Following the sale, the chief executive officer owned 101,197 shares in the company, valued at $58,335,010.65. This represents a 1.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,500 shares of company stock valued at $2,598,450. Company insiders own 3.29% of the company's stock.

Chemed Trading Up 1.4%

Shares of Chemed stock traded up $6.56 during trading on Wednesday, reaching $472.46. The company's stock had a trading volume of 96,987 shares, compared to its average volume of 111,639. The stock has a market capitalization of $6.91 billion, a P/E ratio of 23.00, a price-to-earnings-growth ratio of 2.22 and a beta of 0.50. Chemed Corporation has a one year low of $457.44 and a one year high of $623.61. The stock has a 50-day moving average price of $551.27 and a two-hundred day moving average price of $562.07.

Chemed (NYSE:CHE - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. The company had revenue of $646.94 million for the quarter, compared to analysts' expectations of $641.78 million. Chemed had a net margin of 12.40% and a return on equity of 27.58%. Chemed's quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.20 EPS. As a group, sell-side analysts anticipate that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th were issued a dividend of $0.50 per share. The ex-dividend date was Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a yield of 0.42%. Chemed's payout ratio is currently 9.74%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.